Lung Cancers Completed Phase 2 Trials for Zileuton (DB00744)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070486Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00056004Zileuton in Preventing Lung Cancer in Patients With Bronchial DysplasiaPrevention